Type: Poster
Riccardo Moia, MD1*, Maria Elena Carazzolo2*, Chiara Cosentino1*, Mohammad Almasri1*, Donatella Talotta1*, Valentina Tabanelli3*, Giovanna Motta4*, Federica Melle, PhD5*, Maria Vittoria Sacchi6*, Andrea Evangelista7*, Luca Cividini8*, Maria Chiara Tisi9*, Merli Anna10*, Stefano Fiori5*, Alessandro Re, MD11*, Claudia Castellino12*, Vittorio Ruggero Zilioli13*, Francesco Piazza, MD14*, Paolo Corradini, MD15, Stefan Hohaus16*, Gerardo Musuraca, MD, PhD17*, Francesca Gaia Rossi, MD18*, Benedetta Puccini, MD19*, Federica Cavallo20*, Filippo Ballerini21*, Roberta Sciarra22*, Alice Di Rocco, MD23*, Annalisa Arcari24*, Carola Boccomini25*, Francesco Merli, MD26*, Guido Gini, MD27, Monica Tani28*, Riccardo Bruna, MD29*, Vincenzo Pavone, MD30*, Marco Ladetto, MD31, Sara Galimberti, MD32*, Riccardo Bomben, PhD33*, Valter Gattei, MD33, Ilaria Del Giudice34*, Simone Ferrero, MD35, Stefano Pileri3, Monica Balzarotti36*, Gianluca Gaidano, MD, PhD37 and Carlo Visco, MD38*
1Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
2Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
3Haematopathology Division, IEO European Institute of Oncology IRCCS, Milan, Italy
4Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria of Bologna, Bologna, Italy
5IEO, Istituto Europeo di Oncologia IRCCS - Haematopathology Division, Milano, Italy
6Fondazione Italiana Linfomi, Onlus, Alessandria, Alessandria, Italy
7SSD Epidemiologia Clinica e Valutativa, AOU Città della Salute e della Scienza e CPO Piemonte, Torino, Italy
8Università Del Piemonte Orientale, Novara, ITA
9Hematology Unit, San Bortolo Hospital, A.U.L.S.S. 8 "Berica", Vicenza, Italy
10Ospedale degli Infermi di Rimini - U.O. di Ematologia, Rimini, Italy
11Lymphoma Unit, Division of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
12A.O. S. Croce e Carle - S.C. di Ematologia e Trapianto di Midollo Osseo, Cuneo, Italy
13Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy, Milano, IT-MI, Italy
1412Dipartimento di Medicina, Università degli Studi di Padova, UOC di Ematologia, Azienda Ospedale Università Padova, Padova, Italy
15Hematology Division, University of Milan. Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
16Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy
17IRCCS Istituto Romagnolo per lo studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy
18Ospedale Maggiore Policlinico - Fondazione IRCCS Ca Granda – Ematologia, Milano, Italy
19Unit of Hematology, Careggi University-Hospital, Florence, Italy
20Division of Hematology, University of Torino, Torino, Italy
21IRCCS Ospedale Policlinico San Martino, Genoa, Italy
22Fondazione IRCCS Policlinico San Matteo, Pavia, ITA
23Hematology Section, Department of Traslational and Precision Medicine, Sapienza University of Rome, Roma, Italy
24UO Ematologia, Ospedale Guglielmo da Saliceto, Piacenza, Italy
25SC Ematologia, AOU Città della Salute e della Scienza, Torino, Italy
26Hematology unit, Azienda USL-IRCCS, Reggio Emilia, Italy
27Hematology Unit, AUO Ospedali Riuniti, Università Politecnica delle Marche, Ancona, ITA
28Santa Maria delle Croci Hospital, Ravenna, Italy
29Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont and AOU Maggiore della Carità, Novara, ITA
30Hematology Unit, Azienda C. Panico, Tricase, Italy
31Department of Translational Medicine, Università del Piemonte Orientale ed SCDU Ematologia AOU SS Antonio e Biagio e Cesare Arrigo, Alessandria, Piedmont, Italy
32Department of Clinical and Experimental Medicine, Hematology, University of Pisa, Pisa, Italy
33Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy
34Hematology, Department of Translational and Precision Medicine, Sapienza University, Roma, Italy
35Department of Molecular Biotechnology and Health Sciences, Hematology Division, University of Torino, Torino, TO, Italy
36Hematology, IRCCS Humanitas Research Hospital, Rozzano, Milano, ITA
37Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
38Hematology and Bone Marrow Transplant Unit, Department of Engineering for Innovative Medicine, University of Verona, Verona, Italy
Ilaria Romano, MD1,2, Joyce Marques De Almeida, MD2*, Lodovico Terzi Di Bergamo2*, Alessio Bruscaggin, PhD2*, Saemi Schaer3*, Riccardo Moia, MD4*, Deborah Piffaretti, PhD5*, Maria Cristina Pirosa, MD1,2, Adalgisa Condoluci, MD1,2, Gabriela Forestieri2*, Federico Jauk, MD2*, Matin Salehi2*, Georgia Alice Galimberti2*, Simone Bocchetta, PhD2*, Francesco Bertoni, MD6, Urban Novak, MD7*, Felicitas Hitz, MD8*, Stefan Dirnhofer, MD9*, Jana Musilova3*, Andrea Fuhrer3*, Stefanie Hayoz3*, Luca Ceriani, MD10*, Gianluca Gaidano, MD, PhD4, Anastasios Stathis, MD11,12*, Emanuele Zucca, MD13,14 and Davide Rossi, MD, PhD1,2,14
1Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
2Institute of Oncology Research, Laboratory of Experimental Hematology, Bellinzona, Switzerland
3Swiss Group for Clinical Cancer Research (SAKK) Competence Center, Bern, Switzerland
4Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
5Institute of Oncology Research, Laboratory of Experimental Hematology, Bellinzona, AL, Switzerland
6Lymphoma Genomics, Institute of Oncology Research, Bellinzona, Switzerland
7Department of Medical Oncology, University Hospital Inselspital and University of Bern, Bern, Switzerland
8Oncology/Hematology, Kantonsspital St.Gallen, St. Gallen, Switzerland
9Institute of Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland
10Imaging Institute of Southern Switzerland, Clinic of Nuclear Medicine and Molecular Imaging, Bellinzona, Switzerland
11Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale, Bellinzona, Switzerland
12Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland
13Division of Medical Oncology, Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale, Bellinzona, Switzerland
14Università della Svizzera italiana, Faculty of Biomedical Science, Lugano, Switzerland
Xu Sun, PhD1,2,3*, Yijun Wu, MD2,3,4*, Kai Kang, MD2,3,5*, He Li, MD1*, Ailin Zhao, MD6,7,8* and Ting Niu, MD, PhD1,2,3
1Department of Hematology, West China Hospital, Sichuan University, Chengdu, China
2National Facility for Translational Medicine (Sichuan), West China Hospital, Sichuan University, Chengdu, China
3State Key Laboratory of Biotherapy, Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
4Division of Thoracic Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, AL, China
5Division of Thoracic Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, China
6National Facility for Translational Medicine (Sichuan), West China Hospital, Sichuan University., Chengdu, China
7Department of Hematology, West China Hospital, Sichuan University., Chengdu, China
8State Key Laboratory of Biotherapy, Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University., Chengdu, China
Cristiana Carniti1*, Sadhana Jonnalagadda1*, Giada Zanirato1*, Martina Magni1*, Eugenio Fardella, MD2*, Claudia Castellino3*, Alessandro Re, MD4*, Chiara Ghiggi5*, Filippo Ballerini6*, Rosanna Ciancia7*, Lorella Orsucci8*, Antonio Pinto9,10*, Sara Usai11*, Francesca Gaia Rossi, MD12*, Annalisa Arcari13*, Fiorella Ilariucci14*, Vittorio Ruggero Zilioli15*, Leonardo Flenghi16*, Melania Celli17*, Fabio Benedetti18*, Caterina Patti19*, Caterina Plenteda20*, Manuela Zanni21*, Gerardo Musuraca22*, Riccardo Bruna23*, Luca Arcaini24*, Federica Cavallo25*, Annalisa Chiappella1, Anna Dodero, MD26* and Paolo Corradini, MD27
1Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
2Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
3A.O. S. Croce e Carle - S.C. di Ematologia e Trapianto di Midollo Osseo, Cuneo, Italy
4Lymphoma Unit, Division of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
5UO Ematologia e Terapie Cellulari, IRCCS Ospedale Policlinico San Martino, Genova, Italy
6Hematology, IRCCS Ospedale Policlinico San Martino, Genova, Italy
7Onco-hematology and Stem Cell Transplantation and Cellular Therapies,, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy
8Hematology Division, A.O.U Città della Salute e della Scienza, Ospedale S. Giovanni Battista Molinette, Torino, Italy
9Hematology-Oncology & Stem Cell Transplantation Unit, IRCCS Istituto Nazionale Tumori, Fondazione G. Pascale, Napoli, Italy
10Hematology-Oncology and Stem Cell Transplantation Unit, Istituto Nazionale Tumori, Fondazione ‘G. Pascale’, IRCCS, Naples, Italy
11SC Ematologia e CTMO ARNAS G. Brotzu, Cagliari, Italy
12Ospedale Maggiore Policlinico - Fondazione IRCCS Ca Granda – Ematologia, Milano, Italy
13UO Ematologia, Ospedale Guglielmo da Saliceto, Piacenza, Italy
14Hematology, Azienda USL-IRCCS di Reggio Emilia,, Reggio Emilia, Italy
15Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy, Milano, IT-MI, Italy
16Hematology, Azienda Ospedaliera di Perugia, Perugia, Italy
17Ospedale Degli Infermi Di Rimini, Rimini, Italy
18Department of Engineering for Innovation Medicine, Section of Medicine and Bone Marrow Transplant Unit, Verona University, Verona, Italy
19Onco-Hematology Unit, Azienda Ospedaliera Riunita Villa Sofia-Vincenzo Cervello, Palermo, Italy
20Hematology and CTMO, Azienda Ospedaliera-Universitaria di Parma, Parma, Italy
21Department of Translational Medicine, Università del Piemonte Orientale SCDU Ematologia, AO SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
22Hematology unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy
23Division of Hematology, Ospedale Maggiore Della Carità, Novara, Italy
24Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
25Division of Hematology, AOU Città della Salute e della Scienza di Torino, Torino, Italy
26Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy
27Fondazione IRCCS Istituto Nazionale dei Tumori Milano, University of Milano, Milano, Italy
Christopher J. Forlenza, MD1, David Hoogstra, MD2*, Donald Barkauskas, PhD3*, Lauren Saguilig, MS4*, Suzanne D. Turner, PhD5*, Nina Prokoph, PhD6*, Perla Pucci, PhD6*, Lucy Hare, BMBS, PhD6*, Leila Jahangiri, PhD6*, Rui Wu, MD, PhD7*, Kojo S.J. Elenitoba-Johnson, MD1, Eric J. Lowe, MD8 and Megan S. Lim, MD, PhD1*
1Memorial Sloan Kettering Cancer Center, New York, NY
2Helen Devos Children's Hospital At Spectrum Health, Grand Rapids, MI
3Children’s Oncology Group Operations Statistics and Data Center, Monrovia, CA
4Children's Oncology Group Statistical Center, Monrovia, CA
5University of Cambridge, Department of Pathology, Cambridge, United Kingdom
6University of Cambridge, Cambridge, United Kingdom
7Memorial Sloan Kettering Cancer Center, New York
8Children's Hospital of the King's Daughters, Norfolk, VA
Irit Mazza Avivi, MD1,2*, Miriam Neaman, MD1,3*, Noa Lowenton-Spier1*, Chava Perry, MD1,2*, Erel Joffe, MD1*, Roy Vitkon, MD1*, Vlada Bogol, MSc1*, Yael Michaeli, Phd4*, Noa Gilat, Phd4*, Lynne Itelson, MSc4*, Shahar Zirkin, Phd4*, Jasline Deek, Phd3*, Efstathios Kastritis, MD5*, Karolis Sablauskas, MD6,7*, Skirmante Cernauskiene, MD7*, Vilmantė Vaitekėnaitė, MD7*, Andrius Zucenka, MD8,9, Tomas Papajik, MD, PhD10*, Eva Kriegova, PhD11*, Petr Gajdos12* and Yuval Ebenstein, Phd3,13*
1Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
2Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
3Department of Chemistry, Raymond and Beverly Sackler Faculty of Exact Sciences, Tel Aviv University, Tel Aviv, Israel
4JaxBio Technologies Ltd., Netanya, Israel
5Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
6Institute of Data Science and Digital Technologies, Vilnius University, Vilnius, Lithuania
7Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
8Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
9Hematology and Oncology Department, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
10Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic
11Department of Immunology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic
12Department of Computer Science, Faculty of Electrical Engineering and Computer Science, Technical University of Ostrava, Ostrava, Czech Republic
13Department of Biomedical Engineering, Faculty of Engineering, Tel Aviv Univesity, Tel Aviv, Israel
Samuel Weinschenk, BSc1*, Ulrike Philipp1*, Julia C. Kuehn, MD1*, Katharina J. Müller, MD2*, Josia Fauser, MD3*, David Böckle, MD4*, Inga Gebhard1*, Marta Hinz, BSc1*, Nicolas N. Neidert, MD5*, Sabine Bleul1*, Eliza M. Lauer, MD1*, Jurik A. Mutter, PhD1,6*, Stefan K. Alig, MD6, David Kurtz, MD, PhD6, Jürgen Finke, MD1, Reinhard Marks, MD1*, Maximilian Diehn, MD, PhD7*, Ash A. Alizadeh, MD, PhD6, Peter C. Reinacher, MD8*, Julius Wehrle, MD1*, Dominik Wolf, M.D.9*, Florian Kocher, MD, PhD3*, Björn Chapuy10, Jürgen Beck, MD11*, Marco Prinz, MD12,13*, Louisa von Baumgarten, MD2*, Elisabeth Schorb, MD1*, Justus Duyster, MD14* and Florian Scherer, MD1,15
1Department of Medicine I, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
2Department of Neurology, Ludwig-Maximilians-University of Munich, Munich, Germany & German Cancer Consortium, Partner Site Munich, Munich, Germany
3Department of Internal Medicine V, Haematology & Oncology, Comprehensive Cancer Center Innsbruck (CCCI) and Tyrolean Cancer Research Institute (TKFI), Medical University of Innsbruck (MUI), Innsbruck, Austria
4Department of Hematology, Oncology and Tumor Immunology, Charité - University Medical Center Berlin, Campus Benjamin Franklin, 12203 Berlin, Germany, Berlin, Germany
5Department of Neurosurgery, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany
6Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
7Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA
8Department of Stereotactic and Functional Neurosurgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
9University Hospital of Internal Medicine V (Hematology and Oncology), Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria
10Hematology, Oncology and Cancer Immunology, Charité - University Medical Center Berlin, Campus Benjamin Franklin, Berlin, Germany
11Department of Neurosurgery, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
12Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany
13Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany
14Department of Medicine I, Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
15German Cancer Consortium (DKTK) partner site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany
Minghao Dang, PhD1*, Sherif Seif, MD2*, Maria Jose Acevedo-Calado, PhD1*, Linghua Wang, MD, PhD, MS3*, Bria Gabriel2*, Lauren S. Lewis2*, Lorenzo Gensini, MD2*, Hima Bansal, PhD1*, Melody R. Becnel, MD1, Mahmoud R. Gaballa, MD1, Hans C. Lee, MD4, Oren Pasvolsky, MD1, Krina K. Patel, MD, MSc2, Donna M. Weber, MD1, J Christine Ye, MD1*, Robert Z. Orlowski, MD, PhD1 and Sheeba K. Thomas, MD2
1Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX
4Department of Lymphoma & Myeloma, MD Anderson Cancer Center, Houston, TX
Archibald Enninful1*, Francine M. Foss, MD2, Rong Fan, PhD3* and Mina Xu, MD4*
1Biomedical Engineering, Yale University `, New Haven, CT
2Yale University School of Medicine, Hamden, CT
3Department of Biomedical Engineering, Yale University, New Haven, CT
4Yale University, New Haven, CT
Evgeny Arons, PhD1*, Chin-Hsien Tai, PhD2*, Suraj Joshi, BSc3*, Yuelin Liu3*, Chi-ping Day3*, Mark Raffeld, MD4*, Liqiang Xi, MD4*, Hong Zhou, BS1*, Mory Gould2*, Isaac Shpilman5*, Christopher C. Oakes, PhD6,7,8, Seema A Bhat, MD9, Michael R. Grever, MD9, Kerry A. Rogers, MD9, Hao-Wei Wang, MD, PhD4*, Constance M. Yuan, MD, PhD4*, Cenk Sahinalp10* and Robert J. Kreitman, MD1
1Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD
2Laboratory of Molecular Biology, National Cancer Institute, Bethesda, MD
3Cancer Data Science Laboratory, National Cancer Institute, Bethesda, MD
4Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD
5Laboratory of Molecular Biology, National Cancer Institute, NIH, Bethesda, MD
6Department of Biomedical Informatics, The Ohio State University, Columbus, OH
7Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus
8Division of Hematology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH
9Division of Hematology, The Ohio State University, Columbus, OH
10Cancer Data Science Laboratory, National Cancer Institute, NIH, Bethesda, MD
Bartosz Szmyd, MD1,2*, Kamila Wypyszczak, M.Sc.3,4*, Karolina Miarka-Walczyk, M.Sc.3,4*, Zuzanna Urbanska3,4*, Karolina Krajewska, M.D., Ph.D.3*, Justyna Walenciak, M.D., Ph.D.3*, Agnieszka Wziatek, M.D., Ph.D.5*, Katarzyna Derwich, Prof., M.D., Ph.D.5*, Eryk Latoch, M.D., Ph.D.6*, Maryna Krawczuk-Rybak, Prof., M.D., Ph.D.6*, Dawid Przystupski, M.D.7*, Bernarda Jadwiga Kazanowska, Prof., M.D., Ph.D.7*, Ninela Irga-Jaworska, Prof., M.D., Ph.D.8*, Monika Radwanska, MD, PhD9*, Ewa Dudkiewicz, M.D., Ph.D.10*, Bozenna Dembowska-Baginska, Prof., M.D., Ph.D.11*, Anna Wakulinska, M.D.11*, Katarzyna Babol-Pokora, Ph.D.3*, Tomasz Szczepanski, Prof., M.D., Ph.D.12, Wojciech Mlynarski, Prof., M.D., Ph.D.3* and Agata Pastorczak, Prof., M.D., Ph.D.3,4*
1Department of Neurosurgery and Neurooncology, Barlicki University Hospital, Lodz, Poland, Medical University of Lodz, Lodz, Poland
2Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, AL, Poland
3Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland
4Department of Genetic Predisposition to Cancer, Medical University of Lodz, Lodz, Poland
5Department of Pediatric Oncology, Hematology and Transplantology, Poznan University of Medical Sciences, Poznan, Poland
6Department of Pediatric Oncology and Hematology, Medical University of Bialystok, Bialystok, Poland
7Department of Pediatric Hematology/Oncology and BMT, Wroclaw Medical University, Wroclaw, Poland
8Department of Pediatrics, Hematology and Oncology, Medical University of Gdańsk, Gdańsk, Poland
9Department of Pediatric Oncology and Hematology, College of Medical Sciences, University of Rzeszów, Rzeszow, Poland
10Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, Lublin, Poland
11Department of Oncology, The Children's Memorial Health Institute, Warsaw, Poland
12Department of Pediatric Hematology and Oncology, Medical University of Silesia, Zabrze, Poland
Steven Wang, MD1*, Parisa Mapar2*, Ymke van der Pol, PhD2*, Norbert Moldovan, PhD2*, Normastuti Adhini Tantyo2*, Erik D. van Werkhoven, PhD3,4*, Bart Snieder2*, André Do Brito Valente2*, A. De Jonge5*, Esther Drees, MD2*, Margaretha G.M. Roemer, PhD2*, Bauke Ylstra, PhD6*, Clara Klerk, MD PhD7*, Leonie Strobbe, MD8*, Yorick Sandberg, MD PhD9*, Rinske Boersma10*, Harry R. Koene, MD PhD11*, Hans Pruijt, MD, PhD12*, Koen de Heer, MD, PhD13*, Rozemarijn van Rijn14*, Yavuz M. Bilgin, MD PhD15*, Eva De Jongh, MD16*, Marcel Nijland, MD, PhD17*, Marjolein W.M. van der Poel18*, Ad Koster19*, Laurens Nieuwenhuizen, MD PhD20*, Rob Fijnheer, MD PhD21*, Aart Beeker, MD22, Rogier Mous, MD PhD23*, Vibeke KJ Vergote, MD24*, Joost S.P. Vermaat25, Dirk Michiel Pegtel, PhD26*, Martine E.D. Chamuleau, MD PhD27 and Florent Mouliere, PhD2,28*
1Department of Hematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, Netherlands
2Amsterdam UMC, Amsterdam, Netherlands
3Erasmus University Medical Center Cancer Institute, Rotterdam, Netherlands
4HOVON Foundation, Rotterdam, Netherlands
5Cancer Biology and Immunology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands
6VU University Medical Center, Amsterdam, Netherlands
7Department of Internal Medicine, Dijklanderziekenhuis, Hoorn, Netherlands
8Department of Internal Medicine, Gelreziekenhuizen, Zutphen, Netherlands
9Department of Internal Medicine, Maasstad Hospital, Rotterdam, Netherlands
10Amphia Hospital Breda, Breda, Netherlands
11St. Antonius Hospital, Nieuwegein, NLD
12Jeroen Bosch Ziekenhuis, S-Hertogenbosch, Netherlands
13Department of Internal Medicine, Flevoziekenhuis, Almere, Netherlands
14Medisch Centrum Leeuwarden, Leeuwarden, Netherlands
15Adrz, Goes, Netherlands
16Albert Schweitzer Hospital, Dordrecht, Netherlands
17University Medical Center Groningen and University of Groningen, Groningen, Netherlands
18Department of Internal Medicine, Division of Hematology, GROW school for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, Netherlands
19VieCuri, Venlo, Netherlands
20Department of Internal Medicine, Máxima Medisch Centrum, Eindhoven, Netherlands
21Department of Internal Medicine, Meander Medisch Centrum, Amersfoort, Netherlands
22Spaarne Ziekenhuis, Hoofddorp, Netherlands
23Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands
24Department of Hematology, University Hospitals Leuven, Leuven, Belgium
25Department of Hematology, Leiden University Medical Center, Leiden, Netherlands
26Amsterdam UMC, Location VUMC, Amsterdam, Netherlands
27Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, Netherlands
28Cancer Research UK National Biomarker Centre, University of Manchester, Manchester, United Kingdom
Anu Amallraja1*, Gunes Gundem1*, Dylan Domenico1*, Juan E Arango Ossa1*, Umut Aypar, PhD2*, Jeeyeon Baik, BA, MPH2*, Michael Kluk3*, Shenon Sethi, MBBS2*, Katherine Lopez2*, David A. Qualls, MD4, Gilles Salles, MD, PhD5, Elli Papaemmanuil1, Pallavi Galera, MBBS2 and Ahmet Dogan, MD, PhD6
1Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Pathology and Laboratory Medicine, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
4Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
5Lymphoma Service Chief, Memorial Sloan Kettering Cancer Center, New York, NY
6Memorial Sloan Kettering Cancer Center, New York, NY
Qianru Zhang1*, Wenqiang Yan2*, Lu Sun1*, Guoqing Han3*, Qiaoli Wu4*, Yiran Cui1*, Bolin Liu1*, Feng Zhang1*, Ke Pu3*, Mingchao Zhang3*, Xiaobing Zhang1*, Lugui Qiu1, Qingguo Li4*, Gang An1* and Yuxuan Liu5*
1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2State Key Laboratory of Experimental Hematology, State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood, TIANJIN, China
3Department of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China
4Tianjin Neurosurgical Institute, Tianjin Key Laboratory of Cerebrovascular and Neurodegenerative Diseases, Tianjin Huanhu Hospital, Tianjin, China
5State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Dallas, TX
Eric Liu1*, Amit Verma, MD2, Kith Pradhan, PhD3*, Urvi A. Shah, MD4, Aditi Shastri, MD5, Erik Guillen, MSc6*, Alejandro Sica, MD7*, Gregoire Lauvau, PhD8*, Murali Janakiram, MBBS9 and Paul D. Kassner, Ph.D.10*
1Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY
2Department of Developmental & Molecular Biology, Albert Einstein College of Medicine, Bronx
3Montefiore Einstein Cancer Center, Blood Cancer Institute, Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
4Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
5Blood Cancer Institute, Department of Oncology, University of Vermont, Bronx, NY
6Albert Einstein College of Medicine, Bronx, NY
7Department of Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY
8Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY
9Montefiore Medical Center, Bronx, NY
10RAPT Therapeutics, Inc., South San Francisco, CA
Mathieu Simonin1*, Mathieu Viennot2*, Stéphanie Haouy3*, Stéphane Ducassou4*, Aurélie Phulpin5*, Nathalie Garnier6*, Catherine Curtillet7*, Catherine Paillard, MD, PHD8*, Melissa Barbati9*, Jacinthe Bonneau-Lagacherie10*, Marie-Laure Couec11*, Frederic Millot12*, Liana Carausu13*, Justyna Kanold14*, Isabelle Pellier, PhD15*, Pascale Schneider, MD, PhD16*, Jean-Louis Stephan17*, Camille Leglise18*, Claire Pluchart, MD19*, Charlotte Rigaud, MD20*, Marie-Emilie Dourthe, MD, PhD21*, Pierre-Julien Viailly, PhD2*, Pascaline Etancelin, PharmD22*, Victor Michel, MD23*, Sabah Boudjemaa24*, Bénédicte Jonca25*, Françoise Montravers25*, Thierry Leblanc26*, Judith Landman-Parker27* and Fabrice Jardin, MD, PhD28*
1Sorbonne Université / Trousseau Hospital, Paris / APHP, Paris, France
2INSERM U1245, Cancer and Brain Genomics, Centre Henri Becquerel, University of Rouen, Rouen, France
3CHU Montpellier, Montpellier, France
4CHU de Bordeaux, Hopital Pellegrin, Bordeaux, France
5Pediatric Oncology and Hematology Department, University Hospital of Nancy, Nancy, France
6IHOPE Lyon, Lyon, France
7Department of Pediatric Hematology and Oncology, APHM, La Timone Hospital, Marseille., Marseille, France
8Pediatric Oncology, CHRU Strasbourg, Strasbourg, FRA
9Department of Pediatric Hematology-Oncology, CHRU Lille, Lille, France, Lille, France
10Department of Pediatric Hematology and Oncology, Rennes University Hospital, Rennes, France, Rennes, France
11Pediatric hematology and oncology department, University Hospital of Nantes, Nantes, Nantes, France
12Pediatric Oncology, CHU Poitiers, Poitiers, France
13Department of Pediatric Hematology and Oncology,, Centre Hospitalo-Universitaire de Brest, Brest, France, Brest, France
14Pediatric Oncoloy, CHU Clermont Ferrand, Clermontferrand, FRA
15Pediatric Oncology, CHU Angers, Angers Cedex, FRA
16Pediatric Hematology, Immunology, Oncology and Stem Cells Transplantation, Rouen University Hospital Charles Nicolle CHU Rouen, Rouen, France
17Department of Pediatrics Centre Hospitalier Universitaire Saint-Etienne, Saint-Priest en Jarez, France
18Department of Pediatric Oncology, Hematology, Immunology,, University Hospital of Amiens, Amiens, France
19Pediatric Oncology, CHU de Reims, Reims, FRA
20Pediatric Hematology Department, Gustave Roussy, Villejuif, France
21Department of Pediatric Hematology and Immunology, University Hospital Robert Debré, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France
22Department of Genetic Oncology and Inserm U1245, Centre Henri Becquerel, Rouen, FRA
23Department of Hematology, Center Henri Becquerel, University of Rouen, INSERM UMR1245, Rouen, France, Rouen, France
24Pathology Department, Armand Trousseau University Hospital, AP-HP, Sorbonne Université, Paris, France, Paris, France
25Department of nuclear medicine, University Hospital Tenon, Paris, Paris, France
26Hopital Universitaire Robert-Debré, Paris, France
27Sorbonne Université APHP Hôpital Armand Trousseau, Paris, France
28Department of Hematology, Centre Henri Becquerel, Rouen, France
Anastasia Sobol, MS1*, Stepan Kuznetsov, BS1*, Anton Kremlev, MD1*, Giorgio Inghirami, MD2*, Nathan Fowler, MD1, Nikita Kotlov, PhD3* and Anastasia Nikitina, PhD1*
1BostonGene, Corp., Waltham, MA
2Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY
3BostonGene Corp., Waltham, MA
Emil Ramsø Kyvsgaard1,2,3*, Morten Grauslund4*, Lene Sjö5,6*, Linea Melchior7*, Trine Grantzau4*, Lise Mette Gjerdrum8*, Trine Trab9*, Lærke Sloth Andersen10*, Anne Ortved Gang, MD11*, Marie Fredslund Breinholt12*, Michael Boe Møller13*, Jacob Haaber Christensen, MD, PhD14*, Thomas Stauffer Larsen, MD, PhD15,16*, Michael Roost Clausen, MD, PhD17,18*, Anna Caroline Hasselbalch Riley, MD1,19*, Carsten Utoft Niemann, MD, PhD19,20*, Kirsten Gronbaek, MD, PhD, PR20,21,22,23, Martin Hutchings, MD, PhD19,24 and Simon Husby, MD, PhD2*
1Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark
2Rigshospitalet, Department of Hematology, Copenhagen, Denmark
3Grønbæk Group, Biotech Research and Innovation Centre, BRIC, University of Copenhagen, Copenhagen, Denmark
4Dept, of Pathology, Rigshospitalet, Copenhagen, Denmark, Copenhagen, DNK
5Department of Pathology, Rigshospitalet, Copenhagen, Denmark
6University of Copenhagen, Copenhagen, DNK
7Dept. of Pathology, Rigshospitalet, Copenhagen Ø, DNK
8Zealand University Hospital, Roskilde, DNK
9Dept. Of Hematology, Rigshospitalet, Copenhagen, Denmark, Copenhagen, DNK
10Dept. of Hematology, Rigshospitalet, Copenhagen, Denmark, Copenhagen, DNK
11Copenhagen University Hospital, Herlev, Denmark
12Dept. of Pathology, Herlev Hospital, Copenhagen, Denmark
13Pathology, Odense University Hospital, Odense, Denmark
14Dept. of Hematology, Odense University Hospital, Odense, Denmark
15Department of Hematology, Odense University Hospital, Odense, Denmark, Odense, Denmark
16Department of Clinical Research, University of Southern Denmark, Odense, Denmark
17Aarhus University Hospital, Vejle, DNK
18Vejle Hospital, Vejle, Denmark
19Department of Hematology, Rigshospitalet, Copenhagen, Denmark
20Department of Clinical Medicine, Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark
21Rigshospitalet, University of Copenhagen, Copenhagen N, Denmark
22Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
23The Danish Stem Cell Center (Danstem), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
24Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
Seok Jin Kim, MD, PhD1, SangEun Yoon, MD, PhD2*, Woorim Kang3*, Mauricio Chalita4*, Hong Hoe Koo, MD., PhD5*, Dong-Wook Hyun4*, Hyun Kim4*, Junhun Cho, MD., PhD6* and Won Seog Kim, MD7*
1Samsung Med. Ctr., Seoul, Korea, Republic of (South)
2Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
3CJ Bioscience Inc, Seoul, Korea, Republic of (South)
4CJ Bioscience Inc, Seoul, KOR
5Sungkyunkwan Univ., School of Med. Samsung Medical Ctr., Seoul, KOR
6Department of Pathology and Translational Genomics, Samsung Medical Center, SEOUL, KOR
7Samsung Medical Center, Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
Mary B. Callanan, PhD1*, Caroline Milin, MD, PhD2,3,4*, Marie-Helene Delfau-Larue, MD, PhD5*, Clément Bailly, MD, PhD3*, Clémentine Sarkozy6*, Catherine Thieblemont, MD7, Lucie Oberic, MD8*, Emmanuel Gyan, MD, PhD9, Krimo Bouabdallah, MD10*, Remy Gressin, MD11*, Gandhi Damaj, MD, PhD12*, Olivier Casasnovas, MD13*, Vincent Ribrag, MD14, Samuel Griolet15*, Barbara Burroni, MD16*, Olivier Hermine, MD, PhD17,18, Elizabeth A. Macintyre, MD, PhD19 and Steven Le Gouill, MD, PhD20
1Faculty of medicine, CHU de Dijon, Université de Bourgogne, INSERM 1231, Dijon, France
2Department of nuclear medicine, CHU Nantes, Nantes, France
3CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France
4Department of Nuclear Medicine, University Hospital of Nantes, Nantes, France
5Hôpital Henri Mondor, Creteil, FRA
6Hematology Department, Institut Curie, Saint Cloud, France
7Hemato-Oncology, Hôpital Saint-Louis, APHP, University of Paris, Paris, France
8IUCT - Oncopole, Hematology Department, Toulouse, France
9CHU de Tours, Service d'Hématologie & Thérapie Cellulaire, Centre Hospitalier Universitaire, Tours, France
10Bordeaux university hospital, Haut-Leveque, Department of hematology, Bordeaux, France
11CHU Grenoble, Grenoble, France
12CHU Caen, Caen, France
13François Mitterand Hospital, Dijon, FRA
14Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy Institute of Cancer, Villejuif, France
15LYSARC, Statistics, Pierre-Benite, Lyon, France
16Department of Pathology, Hôpital Cochin, Université de Paris, APHP, Paris, France
17Hematology, Necker Hospital, Greater Paris University Hospitals (AP-HP), Paris, France
18Institut Imagine - INSERM U1163, Paris, France
19Laboratory of Onco-Hematology, Necker Enfants-Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France, Paris, France
20Institut Curie, Saint-Cloud, France
Sabrina Baaklini, PhD1*, Alexandre Sarrabay1*, Adrien Mazuel1*, Bertrand Escaliere1*, Chuang Dong1*, Camille Barthelemy1*, Laurine Gil1*, Laila Dahbi1*, Noushin Mossadegh-Keller, PhD1*, Nathalie Van Acker2*, Pauline Gravelle3*, Jean-Marc Navarro1*, Caroline Huber1*, Romain Fenouil, PhD1*, Romane Trombetta1*, Marine Pujol1*, Philippe Gaulard, MD, PhD4*, Benjamin Riviere, MD5*, Peggy Dartigues, MD6*, Francesco Llamas Gutierrez, MD7*, Celine Pangault8*, Fabrice Jardin, MD, PhD9*, François Lemonnier10*, Gilles Salles, MD, PhD11, Corinne Haioun, MD, PhD12, Gabriel Brisou, MD, PhD13*, Matthew E. Stokes14*, Sahil Seth14*, Maria Ortiz Estevez15*, Camille Laurent, MD, PhD16*, Lionel Spinelli, PhD1*, Mark Kaplan, PhD14*, C. Chris Huang, PhD14*, Anita K. Gandhi, PhD17, Bertrand Nadel, PhD18, Sandrine Roulland, PharmD, PhD1* and Pierre Milpied, PhD1*
1Aix Marseille Université, CNRS, INSERM, Centre d'Immunologie de Marseille-Luminy, Marseille, France
2Institut Universitaire Cancer-Oncopole, CHU Toulouse, Centre de Recherches en Cancérologie de Toulouse, INSERM U1037, Toulouse, France
3INSERM UMR 1037-Cancer Research Center of Toulouse, TOULOUSE, France
4Pathology Department, Henri Mondor University Hospital, AP-HP, Créteil, France
5Pathology Department, Hôpital Gui De Chauliac, Montpellier, France
6Department of Pathology, Gustave Roussy, Villejuif, France
7Department of Pathology, CHU Pontchaillou, Rennes, France
8Pôle Biologie, CHU Rennes, Rennes, France
9Department of Hematology, Centre Henri Becquerel, Rouen, France
10Department of Hematology, Henri Mondor Hospital, CRETEIL, France
11Lymphoma Service Chief, Memorial Sloan Kettering Cancer Center, New York, NY
12Lymphoid Malignancies Department, Henri Mondor University Hospital, AP-HP, Créteil, France
13Institut Paoli-Calmettes, Marseille, France
14Bristol Myers Squibb, Summit, NJ
15Bristol Myers Squibb, Sevilla, Spain
16Pathology Department, Institut Universitaire du Cancer , Oncopole, Toulouse, France
17Hematology, Translational Medicine, Bristol Myers Squibb, Summit, NJ
18Centre D'Immunologie De Marseille-Luminy, Marseilles, France
Upasana Ray1*, Richard J. Jones, PhD1,2* and Robert Z. Orlowski, MD, PhD1,3
1Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
2Asylia Therapeutics, Inc., Houston, TX
3Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX
Brian H. Santich, PhD1*, Linlin Wang, PhD1*, Azeezat Abdulsalam, MS1*, Mallika Vadlamudi, PhD1*, Nico Liebenberg, PhD2*, Amadou Ouattara, MSChE1*, Kandarp Jani, MS1*, Johannes Nagel, PhD2*, Norman LaFrance, MD1* and Charlotte A. Russell, MD3
1Science and Translational Medicine, Y-mAbs Therapeutics Inc, New York, NY
2CMC Development, Y-mAbs A/S, Hørsholm, Denmark
3Clinical Development, Y-mAbs Therapeutics A/S, Hørsholm, Denmark
Tina Bagratuni, PhD1*, Christos Vlachos, PhD2*, Maria Sakkou, PhD3*, Ioannis Kollias1*, Ourania Theologi1*, Nefeli Mavrianou Koutsoukou4*, Christine-Ivy Liacos, MS2*, Kostantina Taouxi4*, Alexandra Papadimou4*, Katerina Chrisostomidou4*, Despina Fotiou, MD4*, Maria Gavriatopoulou4*, Evangelos Terpos, MD, PhD5, Efstathios Kastritis, MD, PhD4* and Meletios-Athanasios Dimopoulos4,6,7
1Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
2National and Kapodistrian University of Athens, Athens, Greece
3National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
4Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
5Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Drosia, Attiki, Greece
6University of Athens School of Medicine, Athens, Greece
7General Hospital of Athens-Alexandra, Llisia, Greece
Miro Nylén1,2*, Leo Meriranta, MD3,4*, Emil Hiitola, MSc1,2*, Maare Arffman, MSc3,4*, Harald Holte, MD, PhD5, Judit Mészáros Joergensen, MD, PhD6*, Peter Brown, MD, PhD7*, Sirkku Jyrkkiö, MD, PhD8*, Mats Jerkeman, MD, PhD9,10, Øystein Fluge, MD, PhD11*, Magnus Björkholm, MD, PhD12*, Lars Møller Pedersen, MD, PhD13,14*, Mikael Eriksson, MD, PhD9,10*, Satu Mustjoki, MD, PhD1,2, Sirpa Leppä, MD, PhD3,4 and Mikko Myllymäki, MD, PhD1,2
1Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland
2Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
3Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
4Applied Tumor Genomics Research Program and Department of Oncology, University of Helsinki, Helsinki, Finland
5Department of Oncology, Oslo University Hospital and KG Jebsen Centre for B cell malignancies, Oslo, Norway
6Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
7Department of Hematology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
8Department of Oncology, Turku University Hospital, Turku, Finland
9Skane University Hospital, Lund, Sweden
10Lund University, Lund, Sweden
11Department of Oncology, Haukeland University Hospital, Bergen, Norway
12Department of Medicine, Karolinska University Hospital, Stockholm, Sweden
13Department of Hematology, Zealand University Hospital, Roskilde, Denmark
14Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
Johnvesly Basappa, PhD1*, Shengchun Wang, PhD1*, Cosimo Lobello, PhD2*, David Rushmore, BS2*, Olga Melnikov3*, Neil Sen, BS4*, Vinay Mallikarjuna, MBBS5*, Priyanka Jain, BS6*, Pin Lu, MD, Ph.D.1*, Y. Lynn Wang, MD, PhD1, Kathy Cai, MD PhD2*, Reza Nejati, MD2, Aaron Goldman, PhD7* and Mariusz Wasik, MD1*
1Fox Chase Cancer Center, Philadelphia, PA
2Fox Chase Cancer Center, PHILADELPHIA, PA
3Eurofin Laboratories, Lancaster, PA
4Philadelphia College of Osteopathic Medicine,, Philadelphia, PA
5Cincinnati Children's Hospital Medical Center, Cincinnati, Cincinatti, OH
6Yale university, New Haven
7Wistar Institute, Philadelphia, PA
Eleni Kalafati1*, Kostantina Taouxi2*, Ourania Theologi1*, Nefeli Mavrianou Koutsoukou2*, Ioannis Kollias1*, Christine-Ivy Liacos, MS2*, Alexandra Papadimou2*, Katerina Chrisostomidou2*, Maria Gavriatopoulou2*, Meletios Dimopoulos, MD2, Evangelos Terpos, MD, PhD3, Nicholas P. Anagnou, MD, PhD4*, Efstathios Kastritis, MD2* and Tina Bagratuni, PhD1*
1Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
2Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
3Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Drosia, Attiki, Greece
4Laboratory of Cell and Gene Therapy, National and Kapodistrian University of Athens, Athens, Greece
Elliot O. Eton, BS1,2,3*, Saravanan Ganesan, PhD2,3, Rebecca M. Murray, BS2,3*, Benjamin H. Durham, MD4, Jae H. Park, MD5, Omar Abdel-Wahab, MD6,7 and Dan A. Landau, MD, PhD2,3*
1Tri-Institutional MD-PhD Program, Weill Cornell Medicine, Rockefeller University, Memorial Sloan Kettering Cancer Center, New York, NY
2Division of Hematology and Medical Oncology and Meyer Cancer Center, Department of Medicine, Weill Cornell Medicine, New York, NY
3New York Genome Center, New York, NY
4Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
5Cell Therapy Service and Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
6Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
7Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY
Xiaodan Luo1*, Wenpu Lai2*, Jianbo Liu1*, Boyun Shi1*, Jianli Tang1*, Danyun Yuan1*, Ao Chen1*, Jiayu Huang1*, Huo Tan1* and Runhui Zheng1*
1The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
2The First Affiliated Hospital of Jinan University, Guangzhou, China
Davidson Zhao1,2, Victoria Shelton, MSc1*, Inna Gong, MD, PhD3, Juan Rangel-Patiño, MD1, Ting Liu, PhD1*, Michael Hong1*, Vanessa Murad, MD4*, Ur Metser4*, Anca Prica, MD3, Vishal Kukreti, MD, MSc5, Sita Bhella, MD3*, Abi Vijenthira, MD, MS3, Michael Crump, MD3*, John Kuruvilla, MD, FRCPC3, Bernard Lam, PhD6* and Robert Kridel, MD, PhD3
1Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
2Department of Medical Biophysics - University of Toronto, Toronto, Canada
3Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
4Department of Medical Imaging, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
5Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
6Ontario Institute for Cancer Research, Toronto, Canada
Benjamin Diamond, MD1, Dhanvantri Chahar, PhD2*, Michael D. Jain, MD, PhD3, Alexandra Maria Poos, PhD4*, Michael Durante, MD, PhD2*, Bachisio Ziccheddu1*, Marcella Kaddoura, MD5, Marios Papadimitriou, MD1*, Kylee H Maclachlan, PhD, BSc, FRACP, FRCPA6, Tomas Jelinek7, Faith E Davies, MD8, Nicholas B Figura, MD9*, Gareth Morgan, M.D., Ph.D.10*, Elias K. Mai, MD4*, Hartmut Goldschmidt, MD11, Katja C. Weisel, MD12, Roland Fenk, MD, PhD13*, Saad Z. Usmani, MD6, Ola Landgren1, Frederick Locke, MD14, Marc S. Raab4*, Jonathan H. Schatz, MD15, Niels Weinhold, PhD4* and Francesco Maura, MD1
1Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
2University of Miami Miller School of Medicine, Miami, FL
3Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
4Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany
5Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Dearborn, MI
6Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
7Department of Hematooncology, University Hospital Ostrava, Ostrava, Ostrava-Mesto, Czech Republic
8NYU Perlmutter Cancer Center, NYU Langone Health, New York, NY
9Department of Radiation Oncology, Moffitt Cancer Center, Tamps, FL
10NYU Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY
11Heidelberg Myeloma Center, Heidelberg, Germany
12Department of Oncology, Hematology and BMT, University Medical Center of Hamburg-Eppendorf, Hamburg, Germany
13Department of Haematology, Oncology, and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany
14Moffitt Cancer Center, Tampa, FL
15University of Miami, Miami, FL